Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Larrey

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Journal De Radiologie|March 21, 2008
[Value of MRCP for diagnosis of biliary complications after liver transplantation]S Aufort, E Molina, E Assenat, et al.
Journal of Viral Hepatitis|July 29, 2015
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patientsJ Boursier, A Ducancelle, J Vergniol, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2006
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective studyC Bonny, H Fontaine, T Poynard, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonR E Poupon, A M Bonnand, P E Queneau, et al.
Journal of Viral Hepatitis|May 20, 2003
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled studyI Portal, M Bourlière, P Halfon, et al.
The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Journal De Radiologie|March 21, 2008
[Value of MRCP for diagnosis of biliary complications after liver transplantation]S Aufort, E Molina, E Assenat, et al.
Journal of Viral Hepatitis|July 29, 2015
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patientsJ Boursier, A Ducancelle, J Vergniol, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2006
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective studyC Bonny, H Fontaine, T Poynard, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonR E Poupon, A M Bonnand, P E Queneau, et al.
Journal of Viral Hepatitis|May 20, 2003
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled studyI Portal, M Bourlière, P Halfon, et al.
The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.
Pageof 23